8/11/2020  5:36:23 PM Chg. -0.800 Volume Bid8/11/2020 Ask8/11/2020 Market Capitalization Dividend Y. P/E Ratio
27.200EUR -2.86% 46,610
Turnover: 1.28 mill.
-Bid Size: - -Ask Size: - 390.32 mill.EUR 0.00% 40.00

Business description

Medios AG, along with its subsidiaries Medios Pharma GmbH and Medios Manufaktur GmbH, has positioned itself in the specialty pharma segment as the go-to source for expertise and solutions. It brings together individual market players in a network of cooperating partners. Specialty pharmaceutical drugs are medications for patients with rare and/or chronic illnesses (for example, cancer, autoimmune diseases, and infectious diseases) that require lengthy and expensive treatment. Medios AG buys, sells and manages investments of innovative companies. The company aims to establish a strategic investment portfolio and to support its governance.
 

Management board & Supervisory board

CEO
Manfred Schneider
Management board
Matthias Gärtner, Christoph Prußeit, Mi-Young Miehler
Supervisory board
Dr. Yann Samson, Joachim Messner, Klaus Buß
 

Company data

Name: Medios AG
Address: Friedrichstraße 113a,D-10117 Berlin
Phone: +49-30-232-566-800
Fax: +49-30-232-566-866
E-mail: info@medios.ag
Internet: www.medios.ag
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 37.08%
IPO date: 7/15/1999

Investor relations

Name: -
IR phone: -
IR Fax: -
IR e-mail: ir@medios.ag

Company calendar

CW 35 | 8/25/2020 Interim Report 2nd Quarter/6 Months
CW 41 | 10/6/2020 General Shareholder Meeting
CW 46 | 11/12/2020 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
37.08%
Tangaroa Management GmbH
 
35.32%
Allianz Global Investors GmbH
 
5.20%
SEB Investment Management AB
 
5.11%
CRANACH-PHARMA GmbH
 
3.43%
Sampo Plc
 
2.99%
Paladin Asset Management Investmentaktiengesellschaft
 
2.93%
Sarka Henkel/ SarkInvest Beteiligungs GmbH
 
2.74%
Taaleri Oyj
 
2.61%
Others
 
2.59%